A new level of collaboration is needed to overcome the current and future challenges facing healthcare globally, according to international research presented recently.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS